Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Rheumatoid Arthritis

Free Subscription Articles published in Clin Exp Immunol Retrieve available abstracts of 23 articles: HTML format

Single Articles

March 2023
1. CHO S, Jang E, Yoon T, Hwang H, et al
   A novel selective spleen tyrosine kinase inhibitor SKI-O-703 (cevidoplenib) ameliorates lupus nephritis and serum-induced arthritis in murine models.
   Clin Exp Immunol. 2023;211:31-45.
   PubMed     Abstract available
   
   
   January 2023
2. ZONG M, Cheng Y, Ye B, Chen S, et al
   Preparation of Mesoporous Silica Nanocarriers Targeting Glucose-6-Phosphate Isomerase Inhibition and Application in the Treatment of Rheumatoid Arthritis.
   Clin Exp Immunol. 2023 Jan 4:uxac116. doi: 10.1093.
   PubMed     Abstract available
   
   
   November 2022
3. WEYAND CM, Wu B, Huang T, Hu Z, et al
   Mitochondria as disease-relevant organelles in rheumatoid arthritis.
   Clin Exp Immunol. 2022 Nov 24:uxac107. doi: 10.1093.
   PubMed     Abstract available
   
   
   September 2022
4. VALLI A, Kuuliala K, Virtanen A, Kuuliala A, et al
   Tofacitinib treatment modulates the levels of several inflammation-related plasma proteins in rheumatoid arthritis and baseline levels of soluble biomarkers associate with the treatment response.
   Clin Exp Immunol. 2022 Sep 17. pii: 6702616. doi: 10.1093.
   PubMed     Abstract available
   
   
   August 2022
5. ZHENG L, Xu L, Hu F, Xue J, et al
   Elevated expression of TAM receptor tyrosine kinase in synovial fluid and synovial tissue of rheumatoid arthritis.
   Clin Exp Immunol. 2022 Aug 11. pii: 6661266. doi: 10.1093.
   PubMed     Abstract available
   
   
   
6. WANG W, Xiang T, Yang Y, Wang Z, et al
   E3 Ubiquitin Ligases STUB1 Contributes to the Th17/Treg Imbalance via the Ubiquitination of Aryl Hydrocarbon Receptor in Rheumatoid Arthritis.
   Clin Exp Immunol. 2022 Aug 9. pii: 6659032. doi: 10.1093.
   PubMed     Abstract available
   
   
   May 2022
7. RUSCITTI P, Berardicurti O, Di Cola I, Di Muzio C, et al
   The hyper-expression of NLRP4 characterizes the occurrence of macrophage activation syndrome assessing STING pathway in adult-onset Still's disease.
   Clin Exp Immunol. 2022;208:95-102.
   PubMed     Abstract available
   
   
   
8. RUSCITTI P, Berardicurti O, Di Cola I, Di Muzio C, et al
   The hyper-expression of NLRP4 characterizes the occurrence of macrophage activation syndrome assessing STING pathway in adult-onset Still's disease.
   Clin Exp Immunol. 2022;208:95-102.
   PubMed     Abstract available
   
   
   
9. XIE Y, Jiang X, Wang P, Zheng X, et al
   SR-A neutralizing antibody: potential drug candidate for ameliorating osteoclastogenesis in rheumatoid arthritis.
   Clin Exp Immunol. 2022;207:297-306.
   PubMed     Abstract available
   
   
   January 2022
10. QIAN S, Xu J, Zhao S, Yang P, et al
    CMTM6: increased circulating level and up-regulated expression in labial salivary glands in patients with primary Sjogren's syndrome.
    Clin Exp Immunol. 2022;207:65-71.
    PubMed     Abstract available
    
    
    December 2021
11. PATEL S, Ramnoruth N, Wehr P, Rossjohn J, et al
    Evaluation of a fit-for-purpose assay to monitor antigen-specific functional CD4+ T cell subpopulations in rheumatoid arthritis using flow-cytometry based peptide-MHC class-II tetramer staining.
    Clin Exp Immunol. 2021 Dec 5. pii: 6453380. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2021
12. OLSSON AM, Povoleri GAM, Somma D, Ridley ML, et al
    miR-155 overexpressing monocytes resemble HLA highISG15 + synovial tissue macrophages from patients with rheumatoid arthritis and induce polyfunctional CD4+ T cell activation.
    Clin Exp Immunol. 2021 Nov 30. pii: 6446881. doi: 10.1093.
    PubMed     Abstract available
    
    
    
13. HANLON MM, Canavan M, Barker BE, Fearon U, et al
    Metabolites as drivers and targets in Rheumatoid Arthritis.
    Clin Exp Immunol. 2021 Nov 27. pii: 6445033. doi: 10.1093.
    PubMed     Abstract available
    
    
    
14. SHIMOJIMA Y, Ichikawa T, Kishida D, Takamatsu R, et al
    Circulating regulatory T cells in adult-onset Still's disease: Focusing on their plasticity and stability.
    Clin Exp Immunol. 2021;206:184-195.
    PubMed     Abstract available
    
    
    September 2021
15. TANG Y, Bai Z, Qi J, Lu Z, et al
    Altered peripheral B lymphocyte homeostasis and functions mediated by IL-27 via activating the mTOR signaling pathway in patients with rheumatoid arthritis.
    Clin Exp Immunol. 2021 Sep 24. doi: 10.1111/cei.13663.
    PubMed     Abstract available
    
    
    August 2021
16. NOCTURNE G, Ly B, Paoletti A, Pascaud J, et al
    Long-term exposure to monoclonal anti-TNF is associated with an increased risk of lymphoma in BAFF-transgenic mice.
    Clin Exp Immunol. 2021;205:169-181.
    PubMed     Abstract available
    
    
    June 2021
17. ROOS LJUNGBERG K, Martinsson K, Wettero J, Svard A, et al
    Circulating anti-citrullinated protein antibodies containing secretory component are prognostic for arthritis onset in at-risk patients.
    Clin Exp Immunol. 2021;204:344-351.
    PubMed     Abstract available
    
    
    
18. TIAN J, Zhou D, Xiang L, Liu X, et al
    MiR-223-3p inhibits inflammation and pyroptosis in monosodium urate-induced rats and fibroblast-like synoviocytes by targeting NLRP3.
    Clin Exp Immunol. 2021;204:396-410.
    PubMed     Abstract available
    
    
    May 2021
19. YAMANE K, Nakamura H, Hamasaki M, Minei Y, et al
    Immune complexome analysis reveals the presence of immune complexes and identifies disease-specific immune complex antigens in saliva samples from patients with Sjogren's syndrome.
    Clin Exp Immunol. 2021;204:212-220.
    PubMed     Abstract available
    
    
    April 2021
20. ISAILOVIC N, Ceribelli A, Cincinelli G, Vecellio M, et al
    Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritis.
    Clin Exp Immunol. 2021 Apr 26. doi: 10.1111/cei.13609.
    PubMed     Abstract available
    
    
    March 2021
21. OSADA A, Matsumoto I, Mikami N, Ohyama A, et al
    Citrullinated inter-alpha-trypsin inhibitor heavy chain 4 in arthritic joints and its potential effect in the neutrophil migration.
    Clin Exp Immunol. 2021;203:385-399.
    PubMed     Abstract available
    
    
    
22. HALPERT G, Halperin Sheinfeld M, Monteran L, Sharif K, et al
    The tellurium-based immunomodulator, AS101 ameliorates adjuvant-induced arthritis in rats.
    Clin Exp Immunol. 2021;203:375-384.
    PubMed     Abstract available
    
    
    February 2021
23. GLENNON-ALTY L, Moots RJ, Edwards SW, Wright HL, et al
    Type I interferon regulates cytokine-delayed neutrophil apoptosis, reactive oxygen species production and chemokine expression.
    Clin Exp Immunol. 2021;203:151-159.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: